Effect of Age on Clinical Outcomes in Phase 1 Trial Participants

Most persons with cancer living in the United States are older than 65 years of age; however, in general, elderly persons are under-represented in clinical trials and outcomes data are lacking. Outcomes data were analyzed of elderly participants (≥65 years of age) enrolled in phase 1 clinical trials...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer control 2015-04, Vol.22 (2), p.235-241
Hauptverfasser:	Mahipal, Amit, Denson, Aaron C, Djulbegovic, Benjamin, Lush, Richard, Kumar, Ambuj, Juan, Tzu-Hua, Schell, Michael J, Sullivan, Daniel M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Age Factors Aged Aged patients Aged, 80 and over Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Clinical trials Clinical Trials, Phase I as Topic - methods Forecasts and trends Human experimentation in medicine Humans Management Middle Aged Neoplasms - drug therapy Outcome Assessment (Health Care) Patient Selection Self-experimentation in medicine Survival Analysis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!